Association between healthy beverage index and nonalcoholic fatty liver disease in the Ravansar noncommunicable disease cohort study.
Beverage quality
Fatty liver
Healthy beverage index
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 Feb 2024
13 Feb 2024
Historique:
received:
12
01
2024
accepted:
10
02
2024
medline:
14
2
2024
pubmed:
14
2
2024
entrez:
13
2
2024
Statut:
epublish
Résumé
The quality of drinks affects the functioning of the liver. In recent decades, the variety of high-calorie and sweet drinks has increased. The objective of this study was to explore the association between Healthy Beverage Index (HBI) and the risk of nonalcoholic fatty liver disease (NAFLD) among adults. We included 6,276 participants aged 35 to 65 from the Ravansar Non-Communicable Disease (RaNCD) cohort study at baseline. NAFLD is defined based on the fatty liver index (FLI), calculated using anthropometric measurements and non-invasive markers. The HBI was developed using a combination of water, low-fat milk, 100% fruit juice, sugar-sweetened beverages, met fluid requirement and % energy from beverages. Logistic and linear regression models were employed to investigate the associations of the HBI and high FLI. The average FLI was significantly lower in the first tertile of HBI compared to the third tertile (47.83 vs. 45.77; P = 0.001). After adjusting for confounding variables, the odds of high FLI decreased by 28% (OR 0.72, 95% CI 0.63, 0.82) in the second tertile of HBI and by 21% in the third tertile (OR 0.79, 95% CI 0.70, 0.91). There was no correlation between gamma glutamyl transferase (GGT), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and aspartate transaminase (AST) levels with HBI. The study findings indicate an inverse association between high FLI and HBI. Therefore, it is recommended to consume healthy beverages and without added sugar. However, additional longitudinal studies are required to examine the association between beverage consumption and the development of NAFLD.
Identifiants
pubmed: 38351106
doi: 10.1038/s41598-024-54288-2
pii: 10.1038/s41598-024-54288-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3622Informations de copyright
© 2024. The Author(s).
Références
Kamari, N. et al. Fatty liver index relationship with biomarkers and lifestyle: result from RaNCD cohort study. BMC Gastroenterol. 23, 1–8 (2023).
doi: 10.1186/s12876-023-02785-5
Darbandi, M. et al. Anti-inflammatory diet consumption reduced fatty liver indices. Sci. Rep. 11, 22601 (2021).
doi: 10.1038/s41598-021-98685-3
pubmed: 34799655
pmcid: 8604894
Zhang, X. et al. Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease. Liver Int. 40, 2719–2731 (2020).
doi: 10.1111/liv.14638
pubmed: 32799384
Sarwar, R., Pierce, N. & Koppe, S. Obesity and nonalcoholic fatty liver disease: current perspectives. Diabetes Metabolic Syndrome Obes.: Targets Therapy, 533–542 (2018).
Teng, M. L. et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin. Mol. Hepatol. 29, S32 (2023).
doi: 10.3350/cmh.2022.0365
pubmed: 36517002
Li, J. et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 4, 389–398 (2019).
doi: 10.1016/S2468-1253(19)30039-1
pubmed: 30902670
Jacobo Cejudo, M. G. et al. The healthy beverage index is not associated with insulin resistance, prediabetes and type 2 diabetes risk in the Rotterdam Study. Eur. J. Nutr. 62, 3021–3031 (2023).
doi: 10.1007/s00394-023-03209-6
pubmed: 37488428
pmcid: 10468439
Jahanbazi, L., Farhangi, M. A., Tousi, A. Z. & Nikrad, N. The Association Between Healthy Beverage Index (HBI) with metabolic risk factors among apparently metabolically healthy overweight and obese individuals. Clin. Nutr. Res. 12, 218 (2023).
doi: 10.7762/cnr.2023.12.3.218
pubmed: 37593211
pmcid: 10432163
Duffey, K. J. & Davy, B. M. The healthy beverage index is associated with reduced cardiometabolic risk in US adults: A preliminary analysis. J. Acad. Nutr. Dietetics 115, 1682–1689 (2015).
doi: 10.1016/j.jand.2015.05.005
Zhou, B. et al. Metabolomic links between sugar-sweetened beverage intake and obesity. J. Obes. 2020 (2020).
Brown, I. J. et al. Sugar-sweetened beverage, sugar intake of individuals, and their blood pressure: International study of macro/micronutrients and blood pressure. Hypertension 57, 695–701 (2011).
doi: 10.1161/HYPERTENSIONAHA.110.165456
pubmed: 21357284
Neelakantan, N., Park, S. H., Chen, G.-C. & van Dam, R. M. Sugar-sweetened beverage consumption, weight gain, and risk of type 2 diabetes and cardiovascular diseases in Asia: A systematic review. Nutr. Rev.s 80, 50–67 (2022).
doi: 10.1093/nutrit/nuab010
Jones, G. S. et al. Sweetened beverage consumption and risk of liver cancer by diabetes status: A pooled analysis. Cancer Epidemiology 79, 102201 (2022).
doi: 10.1016/j.canep.2022.102201
pubmed: 35728406
Park, W. Y. et al. Sugar-sweetened beverage, diet soda, and nonalcoholic fatty liver disease over 6 years: The Framingham Heart Study. Clin. Gastroenterol. Hepatol. 20, 2524–2532 (2022).
doi: 10.1016/j.cgh.2021.11.001
pubmed: 34752964
Chhimwal, J., Patial, V. & Padwad, Y. Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink. Clin. Nutr. 40, 2508–2519 (2021).
doi: 10.1016/j.clnu.2021.04.011
pubmed: 33932796
Poustchi, H. et al. Prospective epidemiological research studies in Iran (the PERSIAN Cohort Study): Rationale, objectives, and design. Am. J. Epidemiol. 187, 647–655 (2018).
doi: 10.1093/aje/kwx314
pubmed: 29145581
Pasdar, Y. et al. Cohort profile: Ravansar Non-Communicable Disease cohort study: the first cohort study in a Kurdish population. Int. J. Epidemiol. 48, 682–683f (2019).
doi: 10.1093/ije/dyy296
pubmed: 30753701
Bedogni, G. et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 1–7 (2006).
doi: 10.1186/1471-230X-6-33
Huang, X. et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in middle-aged and elderly Chinese. Medicine 94 (2015).
Eghtesad, S. et al. Validity and reproducibility of a food frequency questionnaire assessing food group intake in the PERSIAN Cohort Study. Front. Nutr. 10 (2023).
Jalilpiran, Y., Mozaffari, H., Askari, M., Jafari, A. & Azadbakht, L. The association between Healthy Beverage Index and anthropometric measures among children: A cross-sectional study. Eat. Weight Disorders-Stud. Anorexia Bulimia Obes. 26, 1437–1445 (2021).
doi: 10.1007/s40519-020-00954-z
Ma, J. et al. Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts. J. Hepatol. 63, 462–469 (2015).
doi: 10.1016/j.jhep.2015.03.032
pubmed: 26055949
pmcid: 4827616
Abid, A. et al. Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J. Hepatol. 51, 918–924 (2009).
doi: 10.1016/j.jhep.2009.05.033
pubmed: 19765850
Zelber-Sagi, S. et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): A population based study. J. Hepatol. 47, 711–717 (2007).
doi: 10.1016/j.jhep.2007.06.020
pubmed: 17850914
Hallfrisch, J. J. T. F. J. Metabolic effects of dietary fructose. 4, 2652–2660 (1990).
Mayes, P. A. Intermediary metabolism of fructose. Am. J. Clin. Nutr. 58, 754S-765S (1993).
doi: 10.1093/ajcn/58.5.754S
pubmed: 8213607
Nagai, Y. et al. Amelioration of high fructose-induced metabolic derangements by activation of PPARα. Am. J. Physiol. Endocrinol. Metab. 282, E1180–E1190 (2002).
doi: 10.1152/ajpendo.00471.2001
pubmed: 11934685
Uyeda, K. & Repa, J. J. Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4, 107–110 (2006).
doi: 10.1016/j.cmet.2006.06.008
pubmed: 16890538
Roglans, N. et al. Impairment of hepatic Stat-3 activation and reduction of PPARα activity in fructose-fed rats. Hepatology 45, 778–788 (2007).
doi: 10.1002/hep.21499
pubmed: 17326204
Badin, P.-M. et al. Altered skeletal muscle lipase expression and activity contribute to insulin resistance in humans. Diabetes 60, 1734–1742 (2011).
doi: 10.2337/db10-1364
pubmed: 21498783
pmcid: 3114384
Després, J.-P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 126, 1301–1313 (2012).
doi: 10.1161/CIRCULATIONAHA.111.067264
pubmed: 22949540
Choi, J. W. J., Ford, E. S., Gao, X. & Choi, H. K. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: The Third National Health and Nutrition Examination Survey. Arthritis Care Res.: Off. J. Am. College Rheumatol. 59, 109–116 (2008).
doi: 10.1002/art.23245
Gao, X. et al. Intake of added sugar and sugar-sweetened drink and serum uric acid concentration in US men and women. Hypertension 50, 306–312 (2007).
doi: 10.1161/HYPERTENSIONAHA.107.091041
pubmed: 17592072
Lanaspa, M. A. et al. Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome. Nat. Commun. 4, 2434 (2013).
doi: 10.1038/ncomms3434
pubmed: 24022321